DKK655.50
0.38% today
Copenhagen, Sep 22, 05:00 pm CET
ISIN
DK0060055861
Symbol
CHEMM

ChemoMetec Stock price

DKK655.50
+129.00 24.50% 1M
+130.50 24.86% 6M
+169.30 34.82% YTD
+234.70 55.77% 1Y
+38.00 6.15% 3Y
+215.50 48.98% 5Y
+637.14 3,470.63% 10Y
+634.79 3,064.88% 20Y
Copenhagen, Closing price Mon, Sep 22 2025
+2.50 0.38%

Key metrics

Basic
Market capitalization
DKK11.3b
Enterprise Value
DKK11.0b
Net debt
positive
Cash
DKK341.9m
Shares outstanding
17.4m
Valuation (TTM | estimate)
P/E
61.0 | 48.3
P/S
22.8 | 19.5
EV/Sales
22.2 | 18.9
EV/FCF
77.0
P/B
16.8
Dividends
DPS
DKK7.00
Yield 1Y | 5Y
1.1% | 0.6%
Growth 1Y | 5Y
75.0% | 36.1%
Payout 1Y | 3Y
65.4% | 59.0%
Increased
1 Year
Financials (TTM | estimate)
Revenue
DKK495.6m | DKK580.4m
EBITDA
DKK258.1m | DKK337.3m
EBIT
DKK236.5m | DKK288.4m
Net Income
DKK186.4m | DKK235.2m
Free Cash Flow
DKK142.7m
Growth (TTM | estimate)
Revenue
21.5% | 17.1%
EBITDA
38.6% | 25.0%
EBIT
40.0% | 16.1%
Net Income
36.8% | 26.2%
Free Cash Flow
67.0%
Margin (TTM | estimate)
Gross
83.1%
EBITDA
52.1% | 58.1%
EBIT
47.7%
Net
37.6% | 40.5%
Free Cash Flow
28.8%
Financial Health
Equity Ratio
81.3%
Return on Equity
27.7%
ROCE
34.7%
ROIC
53.6%
Debt/Equity
0.0
More
EPS
DKK10.7
FCF per Share
DKK8.2
Short interest
-
Employees
184
Rev per Employee
DKK2.7m
Show more

Is ChemoMetec a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,013 stocks worldwide.

ChemoMetec Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a ChemoMetec forecast:

10x Buy
91%
1x Hold
9%

Analyst Opinions

11 Analysts have issued a ChemoMetec forecast:

Buy
91%
Hold
9%

Financial data from ChemoMetec

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
496 496
22% 22%
100%
- Direct Costs 84 84
3% 3%
17%
412 412
28% 28%
83%
- Selling and Administrative Expenses 154 154
14% 14%
31%
- Research and Development Expense - -
-
-
258 258
39% 39%
52%
- Depreciation and Amortization 22 22
25% 25%
4%
EBIT (Operating Income) EBIT 237 237
40% 40%
48%
Net Profit 186 186
37% 37%
38%

In millions DKK.

Don't miss a Thing! We will send you all news about ChemoMetec directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

ChemoMetec A/S engages in the development, production, and sale of analytical equipment for fluid cell count and analysis. It operates through the following segments: Instruments, Consumer Goods, Service, and Others. The Instruments segment sells NucleoCounter NC-100, NC-200, NC250, and NC-3000. The Consumer Goods segment offers disposable cartridges, disposable analysis chambers, reagents, and test kits. The Service segment provides service packages and its corresponding guarantees. The Others segment offers measuring modules and accessories. The company was founded by Hans Martin Glensbjerg in 1977 and is headquartered in Allerod, Denmark.

Head office Denmark
CEO Mr. Behrens
Employees 184
Founded 1997
Website chemometec.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today